Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapyYing Gong, Wilfred T.V. Germeraad|Journal of Hematology & Oncology|2021Cited by 364
NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibodyYing Gong, Roel G. J. Klein Wolterink|Molecular Therapy|2024Cited by 28